THIRD INTERNATIONAL CONFERENCE ON ANTIVIRAL RESEARCH

这项提案要求提供资金，以便将旅费赠款授予 美国科学家为了让他们参加第三届 国际抗病毒研究会议将在布鲁塞尔举行， 比利时，1990年4月22日至27日。它的力量和重要性 会议的重点是介绍关于不同和多学科的数据 抗病毒药物开发的所有阶段从药物设计和 通过人类控制的研究进行合成。大力支持和支持 顶尖研究人员以及基础广泛的 国际出席为这一点提供了更多的科学意义 开会。这次会议的组织者是：Richard Whitley博士(大学 阿拉巴马州伯明翰分校)和Erik DeClercq博士(雷加研究所)。这个 计划委员会成员：George Galasso William Shannon博士(南区 研究所)，休·菲尔德(剑桥大学)，汉斯·埃格斯 (科隆大学)，Peter Palese(Mt.西奈大学)和理查德 沃克(伯明翰大学)，除了惠特利博士和 德勒克。课程内容包括：药物的分子靶点。 发展，抗病毒药物的合成化学，分子 药物活性的生物化学和药理学，药效学， 药代动力学，体外和体内分析系统，以及受控人 审判。

This proposal requests funds such that travel grants can be awarded to American scientists in order to allow them to attend the Third International Conference on Antiviral Research to be held at Brussels, Belgium, from April 22-27, 1990. The strength and the importance of this meeting rests on the presentation of data on diverse and multidisciplinary aspects of all phases of antiviral drug development from drug design and synthesis through human controlled investigations. The strong support and participation of leading researchers as well as the broad-based international attendance provide further scientific significance to this meeting. Organizers for this meeting are: Dr. Richard Whitley (University of Alabama at Birmingham) and Dr. Erik DeClercq (Rega Institute). The Program Committee includes: Drs. George Galasso William Shannon (Southern Research Institute), Hugh Field (Cambridge University), Hans Eggers (University of Cologne), Peter Palese (Mt. Sinai University), and Richard Walker (University of Birmingham), in addition to Drs. Whitley and DeClercq. The topics to be covered include: molecular targets for drug development, the synthetic chemistry of antiviral drugs, the molecular biochemistry and pharmacology of drug activity, pharmacodynamics, pharmacokinetics, in vitro and in vivo assay systems, and controlled human trials.